A
$ Value
$0
Shares
118,367
Price
$0
Filed
Mar 10
Insider
Name
Pauza Charles David
Title
Chief Science Officer Virology
CIK
0002018150
Roles
Officer
Transaction Details
Transaction Date
2026-03-08
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
118,367
Footnotes
Represents stock options awarded by the Issuer's compensation committee (comprised of independent directors) to the reporting person under the Issuer's 2021 Incentive Compensation Plan, as amended and/or restated through the date hereof. The stock options under this award will vest 100% on the first anniversary of the grant date.
Filing Info
Pauza Charles David's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-08 | TRAW | A | $0 |
| 2025-12-12 | TRAW | A | $0 |
| 2025-12-12 | TRAW | A | $0 |
| 2025-10-12 | TRAW | A | $0 |
Other Insiders at TRAW (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| STOVER JACK E | — | — | 2026-03-08 |
| CAUTREELS WERNER | — | — | 2026-03-08 |
| Leaman John Harold | — | — | 2026-03-08 |
|
Dukes Iain D.
Chief Executive Officer
|
— | — | 2026-03-08 |
| Shoemaker Mary Teresa | — | — | 2026-03-08 |
| Clarke Trafford | — | — | 2026-03-08 |
|
Savchuk Nikolay
Chief Operating Officer
|
— | — | 2026-03-08 |
|
Redfield Robert
Chief Medical Officer
|
— | — | 2026-03-08 |
|
Parker Charles Nolan
Chief Financial Officer
|
— | — | 2026-03-08 |